Type 2 & other diabetes

Serum Metabolomic Profiling of Incident Type 2 Diabetes Mellitus in the Multi-ethnic Study of Atherosclerosis and Rotterdam Study

J Clin Endocrinol MetabPublished Metabolomic cohort study with replication and Mendelian randomization

Authors' conclusion

1H NMR measured metabolites involved in aminoacyl-tRNA biosynthesis, BCAA metabolism, glycolysis/gluconeogenesis, and glycerolipid metabolism were significantly associated with incident T2DM and provided modest to moderate predictive utility beyond traditional risk factors.

Study context

Population
Participants of the Multi-Ethnic Study of Atherosclerosis (MESA) and the Rotterdam Study (RS)
Participants
3,460 vs 1,556
Exposure
MESA vs RS
  • MESAn = 3,460
  • RSn = 1,556
Outcome
Serum metabolomic biomarkers associated with incident T2D
Methodological detailsuntargeted 1H NMR metabolomics, discovery and replication cohorts, 2-sample Mendelian randomization
  • Untargeted 1H NMR metabolomics
  • Discovery and replication cohorts
  • 2-sample Mendelian randomization

Main finding

As reported in the abstract

Metabolites associated with incident T2D
Metabolites significantly associated with incident T2D
19

Observational data: associations, not effects.

Further findings

Δ C-statistic

OutcomeMESARS
Improvement in T2D risk prediction adding replicated metabolites to Framingham Diabetes Risk Score (Δ C-statistic)0.05 (95% CI 0.04–0.07)0.03 (95% CI 0.01–0.05)

Network analyses

Interactions with upstream regulators incl. p38 MAPK, JNK and mTOR signaling pathways

Mendelian randomization

Genetically increased branched-chain amino acids (BCAAs) and mannose were associated with T2D

Original publication

Serum Metabolomic Profiling of Incident Type 2 Diabetes Mellitus in the Multi-ethnic Study of Atherosclerosis and Rotterdam Study. J Clin Endocrinol Metab. Published 20 November 2024. doi:10.1210/clinem/dgae812

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.